Knowledge Exchange
Below you will find the presentations and slides shared from the Sichuan University (West China Hospital)-Oxford University Gastrointestinal Cancer Centre Seminar Series.
If any information is missing from this section, please contact David Kerr about getting it added to the website.
Featured Presentations
Slides & Documents
Protein acylation and tumour progression - Prof Hongquan Zhang
Progression in neoadjuvant immunotherapy for local advanced CRC - Prof Meng Qiu
Slides & Documents
Protein acylation and tumour progression - Prof Hongquan Zhang
Progression in neoadjuvant immunotherapy for local advanced CRC - Prof Meng Qiu
Available Projects
Below you will find the Oxford principle investigator gastrointestinal research projects, available for collaboration opportunities as part of the Sichuan University (West China Hospital)-Oxford University Gastrointestinal Cancer Centre
Dr Eileen Parkes
Characterising the tumour microenvironment in oesophageal squamous cell and adenocarcinomas
Dr Shijie Cai
Prof David Kerr
Metabolic and inflammatory cross-feeding regulates multiple cellular component interactions in the colorectal tumour microenvironment: Implications of cancer biomarker identification and therapy development
Dr Francesco Boccellato
Modelling stroma-epithelium communication in the healthy and in the tumorous gastric mucosa
Dr David Church
Mechanisms and consequnces of MHC class I & II dysregulation in colorectal cancer
Dr Geng Liu
Prof Nick La Thangue
The role of immune-modulation in the anti-cancer activity of histone deacetylase inhibitor-based drugs in colorectal cancer
Dr Sivan Sivakumar
Understanding the immune landscape of pancreatic cancer
Prof Rachel Kerr
(WINDOW-101): A window of opportunity, biomarker discovery study of CXD101 +/- Nivolumab in patients with operable microsatellite stable colorectal cancer
Prof Sir Walter Bodmer
The interaction between myofibroblasts and epithelial cells in the colorectal cancer microenvironment
Prof Francesco Pezzella
Dr Shijie Cai
Prof David Kerr
Is the VEGF pathway mediating also tumour suppression and non-angiogenic growth?
